AQR Capital Management LLC lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 25.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,065,677 shares of the real estate investment trust's stock after selling 368,773 shares during the period. AQR Capital Management LLC owned 0.15% of Healthpeak Properties worth $21,548,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in DOC. TCTC Holdings LLC raised its stake in shares of Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 751 shares in the last quarter. Brooklyn Investment Group raised its stake in shares of Healthpeak Properties by 198.9% during the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 873 shares in the last quarter. Future Financial Wealth Managment LLC bought a new stake in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. S.A. Mason LLC raised its stake in shares of Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after purchasing an additional 925 shares in the last quarter. Finally, Dagco Inc. bought a new stake in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. Institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the company. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Wells Fargo & Company decreased their target price on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their target price for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Finally, Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and an average price target of $21.50.
Get Our Latest Report on Healthpeak Properties
Insider Activity
In related news, CEO Scott M. Brinker bought 1,490 shares of Healthpeak Properties stock in a transaction dated Monday, August 4th. The shares were bought at an average cost of $16.83 per share, with a total value of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This trade represents a 0.71% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Over the last quarter, insiders acquired 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Stock Performance
NYSE DOC traded down $0.04 on Friday, reaching $18.10. The stock had a trading volume of 4,343,202 shares, compared to its average volume of 6,111,745. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The firm has a fifty day moving average of $17.76 and a two-hundred day moving average of $18.18. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26. The company has a market cap of $12.58 billion, a P/E ratio of 75.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.07.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. During the same period in the prior year, the firm posted $0.45 EPS. The company's revenue for the quarter was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The business also recently announced a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.7%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties's dividend payout ratio is 508.33%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.